… to the biological behavior of lung cancer, and their utility … lung cancer pathogenesis and
their timing in preneoplasia, primary cancer, and metastatic disease and the clinical implications …

… of molecular and biologic changes in lung cancer cells. This review … lung cancer pathogenesis
to clinical practice. The challenge is to translate discoveries regarding how lung cancers …

… lung cancer cells during their pathogenesis. , 6 Much more is known about the molecular
abnormalities that occur in clinically overt lung cancers… of genes in individual lung cancers, with …

… mechanisms underlying molecular heterogeneity in lung cancer, including epigenetic
mechanisms, … molecular heterogeneity involved in therapeutic implications in lung cancer patients. …

… To gain further insights in the role of EGFR in lung carcinogenesis, we sequenced exons
18… with lung cancer who underwent surgical resection and correlated the results with clinical …

… cancer-related genes in lung cancer, occurs already in smoking-damaged bronchial epithelium
from cancer-free … agents, and may be a useful biomarker for lung cancer risk assessment. …

… I disease (tumor confined to the lung without distant metastases or positive lymph nodes). …
-cell lung cancer (NSCLC) and has the best prognosis.Nonetheless, the cancer relapse and …

… Molecular mechanisms underlying tumorigenesis and development of lung cancer are …
cancers. However, the expression patterns and clinical implications of circRNAs in lung cancer …

… Objective: We sought to assess the clinical implication and prognostic significance of
maximum standardised uptake value (SUV max ) of primary non-small cell lung cancer (NSCLC) …

… In this review, we summarize the characteristic genetic and epigenetic changes observed
in lung cancers and the implication of these changes in patients for early detection, survival …